In this video, Dr. Bobby Lazzara discusses a recent study trial that examined the use of twice daily soaking baths vs. twice weekly soaking baths in a small pediatric population with atopic dermatitis.
Methotrexate and cyclosporine appear to have better safety profiles over a six-month period than other systemic treatments used to treat atopic dermatitis, according to a recent study.
Abnormal proliferation of the Demodex mites is frequent among patients with erythematotelangiectatic rosacea (ETR), according to one expert.
The United States Food and Drug Administration has granted Galderma’s nemolizumab a Breakthrough Therapy Designation following phase 2 results which suggests the drug is a considerable alleviant for pruritus associated with prurigo nodularis.
A new online resource called the Understand AD Squad aims to help teens navigate real-life experiences with atopic dermatitis.
Dr. Mark Beaty uses two radiofrequency treatments that, he says, stand out for skin tightening and wrinkles.
Biosimilar to Remicade
In the video, Dr. Lazzara discusses a study that examined the initial effects of a single use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.
Norman Levine, M.D., discusses the potential benefits and pitfalls of retiring from dermatology.
Collaboration between Leo Pharma and Portal Instruments brings needleless drug delivery device to forefront of dermatology industry
Leo Pharma A/S and Portal Instruments are now collaborating on a new needle-free handheld jet injector for patients that self-administer medicines for cutaneous diseases and ailments.